Clinical trial
Effect of Timing of Surgery After Neoadjuvant Chemoradiation on Histopathological Results, Complications, Recurrence and Survivals for Locally Advanced Rectal Cancer
NCT03287843 is registered in ClinicalTrials.gov with Ege University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Timing of Surgery After Neoadjuvant Chemoradiation on Histopathological Results, Complications, Recurrence and Survivals for Locally Advanced Rectal Cancer
- Lead sponsor
- Ege University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2006
- Completion date
- January 1, 2022
- Enrollment
- 350 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
neoplasm, rectum